Prevalence of risk of thrombosis and of bleeding and antithrombotic treatment in patients with heart failure

Massimo Pozzoli; Jose Gonzalez-Costello; Antoni Bayes-Genis; Gianfranco Sinagra; Stefan D Anker; Andrew J S Coats; Marisa G Crespo-Leiro; Gerasimos Filippatos; Cécile Laroche; Aldo P Maggioni; Alexandre Mebazaa; Massimo F Piepoli; Luigi Tavazzi; ESC Heart Failure Long-Term Registry Investigators Group

doi:10.1002/ejhf.1789

Prevalence of risk of thrombosis and of bleeding and antithrombotic treatment in patients with heart failure

Eur J Heart Fail. 2020 May;22(5):906-910. doi: 10.1002/ejhf.1789. Epub 2020 Mar 30.

Authors

Massimo Pozzoli¹, Jose Gonzalez-Costello², Antoni Bayes-Genis³, Gianfranco Sinagra⁴, Stefan D Anker^{5

6

7}, Andrew J S Coats⁸, Marisa G Crespo-Leiro⁹, Gerasimos Filippatos¹⁰, Cécile Laroche¹¹, Aldo P Maggioni^{11

12}, Alexandre Mebazaa^{13

14

15}, Massimo F Piepoli¹⁶, Luigi Tavazzi¹; ESC Heart Failure Long-Term Registry Investigators Group

Affiliations

¹ Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
² Heart Disease Institute, Hospital Universitari de Bellvitge, IDIBELL, University of Barcelona, Barcelona, Spain.
³ Hospital Universitario Germans Trias i Pujol, Heart Institute, Badalona, Barcelona, Spain.
⁴ Cardiovascular Department, Azienda Sanitaria Universitaria Integrata, University of Trieste, Trieste, Italy.
⁵ Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité Universitätsmedizin Berlin, Berlin, Germany.
⁶ Berlin-Brandenburg Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁷ Department of Cardiology and Pneumology, University Medicine Göttingen (UMG), Göttingen, Germany.
⁸ San Raffaele IRCCS, Pisana, Rome, Italy.
⁹ Unidad de Insuficiencia Cardiaca y Trasplante Cardiaco, Complexo Hospitalario, Universitario A Coruna (CHUAC), INIBIC, UDC, CIBERCV, La Coruna, Spain.
¹⁰ National and Kapodistrian University of Athens, School of Medicine, University Hospital Attikon, Athens, Greece.
¹¹ EURObservational Research Programme, European Society of Cardiology, Sophia- Antipolis, France.
¹² ANMCO Research Center, Florence, Italy.
¹³ INSERM, U942, BIOmarkers in CArdioNeuroVAScular Diseases, Paris, France.
¹⁴ Department of Anesthesiology and Critical Care, APHP, Saint Louis Lariboisière Hospitals, Paris, France.
¹⁵ Université Paris Diderot, Paris, France.
¹⁶ Heart Failure Unit, Cardiac Department, G. da Saliceto Hospital, AUSL, Piacenza, Italy.

PMID: 32232914
DOI: 10.1002/ejhf.1789

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Fibrinolytic Agents / adverse effects
Heart Failure* / drug therapy
Heart Failure* / epidemiology
Hemorrhage / chemically induced
Hemorrhage / epidemiology
Humans
Prevalence
Thrombosis* / drug therapy
Thrombosis* / epidemiology
Thrombosis* / prevention & control

Substances

Fibrinolytic Agents